Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy

Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy

US Patent 10662246 · Granted May 26, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2022
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2019
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Method for treating amyloid disease2017
Mucosal immunization to prevent prion infection2017
Humanized single-chain antibody against beta 3 integrin for the treatment and pr2017
Method for treating amyloid disease2016
Method for treating amyloid disease2016